Lili Hou1, Caicun Zhou2, Yifan Wu1, Ying Yu1, Yinqing Hu1. 1. Department of Nursing, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, China. 2. Department of Oncology and Cancer Institute, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, China.
Abstract
BACKGROUND: To explore the effectiveness of transcutaneous electrical acupoint stimulation (TEAS) approach on cancer-related fatigue (CRF) in non-small cell lung cancer (NSCLC) chemotherapy patients. METHODS: A total of 162 participants who treated withgemcitabine combined with platinum-based drugs (GP chemotherapy) were randomly assigned to three groups: Control (Group A, n=56), Sham TEAS (Group B, n=49), and TEAS (Group C, n=57). The following acupoints were used in this study: Qihai (CV6), Keshu (UB17), and Zusanli (ST36). The Revised Piper Fatigue Scale (RPFS) were used to measure CRF on the day before chemotherapy (P1), days 8 (P2) and 28 (P3) separately. The Differences among three groups were analyzed. RESULTS: At the 28th day, the outcomes of the fatigue scores for Group C, Group B and Group A were 2.06±0.90, 2.80±1.34, 3.00±1.29 respectively. There were significantly different among three groups (F=9.784, P<0.01). At the 28th day, the outcomes of the affective fatigue (F=8.161, P<0.01), sensory fatigue (F=3.06, P=0.05) and cognitive fatigue (F=8.06, P<0.01) for Group C, Group B and Group A were significantly different among three groups. CONCLUSIONS:Chemotherapy may increase the fatigue from P1 to P2 and P3 in NSCLC patients. And TEAS could help to relived CRF, especially at P3.
RCT Entities:
BACKGROUND: To explore the effectiveness of transcutaneous electrical acupoint stimulation (TEAS) approach on cancer-related fatigue (CRF) in non-small cell lung cancer (NSCLC) chemotherapy patients. METHODS: A total of 162 participants who treated with gemcitabine combined with platinum-based drugs (GP chemotherapy) were randomly assigned to three groups: Control (Group A, n=56), Sham TEAS (Group B, n=49), and TEAS (Group C, n=57). The following acupoints were used in this study: Qihai (CV6), Keshu (UB17), and Zusanli (ST36). The Revised Piper Fatigue Scale (RPFS) were used to measure CRF on the day before chemotherapy (P1), days 8 (P2) and 28 (P3) separately. The Differences among three groups were analyzed. RESULTS: At the 28th day, the outcomes of the fatigue scores for Group C, Group B and Group A were 2.06±0.90, 2.80±1.34, 3.00±1.29 respectively. There were significantly different among three groups (F=9.784, P<0.01). At the 28th day, the outcomes of the affective fatigue (F=8.161, P<0.01), sensory fatigue (F=3.06, P=0.05) and cognitive fatigue (F=8.06, P<0.01) for Group C, Group B and Group A were significantly different among three groups. CONCLUSIONS: Chemotherapy may increase the fatigue from P1 to P2 and P3 in NSCLCpatients. And TEAS could help to relived CRF, especially at P3.
Authors: Jennifer M Jones; Karin Olson; Pamela Catton; Charles N Catton; Neil E Fleshner; Monika K Krzyzanowska; David R McCready; Rebecca K S Wong; Haiyan Jiang; Doris Howell Journal: J Cancer Surviv Date: 2015-04-16 Impact factor: 4.442
Authors: Pieter C Dagnelie; Madelon C G Pijls-Johannesma; Anouk Pijpe; Brigit J E Boumans; Arno T P Skrabanja; Philippe Lambin; Gertrudis I J M Kempen Journal: J Clin Epidemiol Date: 2006-06 Impact factor: 6.437
Authors: Annalisa Giacalone; Jerry Polesel; Angela De Paoli; Anna Maria Colussi; Ivana Sartor; Renato Talamini; Umberto Tirelli Journal: Support Care Cancer Date: 2009-09-26 Impact factor: 3.603
Authors: Sandra A Mitchell; Susan L Beck; Linda Edwards Hood; Karen Moore; Ellen R Tanner Journal: Clin J Oncol Nurs Date: 2007-02 Impact factor: 1.027